DA Davidson Reiterates Buy Rating on UCB
DA Davidson maintains its buy rating on UCB with a $40 price target, a 15.51% upside from the current price.
Key Points
- DA Davidson reiterated its buy rating on UCB, setting a price target of $40 on June 15, 2026.
- DA Davidson's $40 price target implies 15.51% upside from United Community Banks, Inc.'s ($UCB) current $34.63 share price.
- UCB shares are trading at $34.63, with institutional activity showing mixed changes among major funds.
- Recent insider buying at UCB includes purchases by several executives, while analysts maintain positive outlooks.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
DA Davidson has reiterated its buy rating on UCB, setting a new price target of $40. This reaffirmation came on June 15, 2026, as the stock traded at $34.63.
Other Institutional Activity in UCB
BlackRock, Inc. reduced its holdings in UCB by 90,024 shares, holding 17,861,636 shares valued at approximately $562.5 million. FMR LLC also trimmed its position by 156,450 shares, ending with 8,950,235 shares worth about $281.8 million. In contrast, Vanguard Portfolio Management LLC initiated a position with 8,044,992 shares valued at $253.3 million. Dimensional Fund Advisors LP increased its stake by 182,397 shares, bringing its total to 6,520,132 shares valued at $205.3 million. State Street Corp also boosted its holdings by 262,394 shares, totaling 6,232,961 shares worth nearly $197.8 million.
United Community Banks, Inc. Stock Down 1.6%
UCB shares are currently trading at $34.63. The stock has seen varied institutional activity, with some funds reducing and others increasing their positions.
Insider Buying and Selling at United Community Banks, Inc.
Recent insider activity at UCB includes a sale by Alan Kumler, SVP and Chief Accounting Officer, who sold 113 shares at an average price of $32.06 on May 15, 2026. On May 13, 2026, several insiders, including David Wilkins, Sally Pope Davis, James Clements, Jennifer Mann, and Kenneth Daniels, each acquired 2,330 shares, although the price was not disclosed.
Analysts Set New Price Targets
On June 15, 2026, DA Davidson maintained its buy rating for UCB with a $40 price target. Previously, on April 28, 2026, Stephens & Co. also maintained a buy rating with the same target. Piper Sandler kept a hold rating with a $36 target on April 22, 2026. Keefe, Bruyette & Woods upgraded UCB to a buy with a $40 target on April 9, 2026.
About UCB
UCB is a global biopharmaceutical company that focuses on discovering and developing innovative medicines and solutions for people living with severe diseases in immunology and neurology. The company operates globally, with headquarters in Brussels, Belgium.
Bottom Line
DA Davidson's reiteration of a buy rating with a $40 target reflects continued confidence in UCB's prospects. Investors often track these analyst updates as they can provide insights into the company's potential. However, it's important to remember that these ratings are opinions and not guarantees of future performance.
Get United Community Banks, Inc. alerts
New 13F filings, insider trades, and analyst moves on $UCB, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.